コラーゲン技術研修会 Company Profile

Reagents for research related to type II and type IV collagen (various sources), for the creation of arthritis and nephritis models.

Our company has been working to promote and utilize collagen research for over 30 years. The type II collagen, which was the first in the world to be commercialized in 1981, is used by all domestic pharmaceutical companies as an inducer of rheumatoid arthritis and has led to the current rheumatoid arthritis treatments. Similarly, we established a purification method for the non-helical region of type IV collagen as an inducer for nephritis models.